文献速递腹部泌尿生殖MR

压缩感知三维磁共振胰胆管成像联合非接触式生理监测在胰胆疾病中的应用

Application of Compressed Sensing 3D MR cholangiopancreatography (CS-MRCP) with Contact-Free Physiological Monitoring (CFPM) for Pancreaticobiliary Disorders.
PubMed 文献 · Acad Radiol · 2021-10-30

前瞻性纳入63例疑似胆胰管病变患者,随机行CS-CFPM-MRCP、CS-NT-MRCP和NT-MRCP三种方案,比较采集时间与图像质量。CS-CFPM-MRCP采集时间较NT-MRCP显著缩短,整体图像质量与NT-MRCP无显著差异,对胰管和肝内胆管显示优于CS-NT-MRCP,诊断胰管解剖相关异常的AUC与NT-MRCP相当且高于CS-NT-MRCP。

要点

  • CS-CFPM-MRCP采集时间较NT-MRCP显著缩短(P<0.001),整体图像质量与NT-MRCP无显著差异。
  • CS-CFPM-MRCP显示胰管和肝内胆管优于CS-NT-MRCP(P<0.05),与NT-MRCP相当(P>0.05)。
  • 诊断胰管解剖相关异常时,CS-CFPM-MRCP的AUC为0.905,高于CS-NT-MRCP的0.713。

核心结论

  • 压缩感知联合非接触式生理监测用于缩短三维自由呼吸MRCP扫描时间可行,且不损害图像质量,CS-CFPM-MRCP对疑似胰胆疾病患者可行。

研究设计与样本

  • 前瞻性研究,纳入63例疑似胆胰管相关病变患者(男36例、女27例,年龄18-83岁,平均52.30±15.70岁),随机采用三种MRCP方案扫描。

关键影像表现/征象

  • CS-CFPM-MRCP对胰管和肝内胆管的显示评分优于CS-NT-MRCP(均P<0.05)。
  • CS-CFPM-MRCP对胰管和肝内胆管的显示评分与NT-MRCP相当(均P>0.05)。
  • CS-CFPM-MRCP与NT-MRCP整体图像质量无显著差异(P>0.05)。

诊断标准与关键数值

  • 胆胰系统分为12个节段,采用五分Likert量表评分。
  • 识别胰管解剖相关异常和疾病:NT-MRCP的AUC为0.896(95%CI: 0.834, 0.958)。
  • 识别胰管解剖相关异常和疾病:CS-CFPM-MRCP的AUC为0.905(95%CI: 0.846, 0.964)。
  • 识别胰管解剖相关异常和疾病:CS-NT-MRCP的AUC为0.713(95%CI: 0.622, 0.805)。
  • CS-CFPM-MRCP的AUC显著高于CS-NT-MRCP(P<0.001);NT-MRCP的AUC显著高于CS-NT-MRCP(P=0.001)。

临床应用与阅片要点

  • CS-CFPM-MRCP可在不损害整体图像质量的前提下缩短三维自由呼吸MRCP扫描时间。
  • 评估胰管和肝内胆管时,CS-CFPM-MRCP的图像质量优于CS-NT-MRCP,与NT-MRCP相当。
  • 观察者间一致性良好至优秀(Kendall's W 0.619-0.897)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONAL AND OBJECTIVES: To prospectively evaluate the clinical feasibility of the magnetic resonance cholangiopancreatography (MRCP) protocol using both contact-free physiological monitoring (CFPM) and compressed sensing (CS) (CS-CFPM-MRCP) and to compare its performance with that of the standard navigator-triggered (NT) CS-NT-MRCP and NT-MRCP.

MATERIALS AND METHODS: A total of 63 patients (36 males, 27 females, age range: 18-83 years, mean age: 52.30 ± 15.70 years) suspected with duct-related pathologies were prospectively enrolled and performed the three MRCP protocols randomly. The acquisition time was compared. The pancreaticobiliary system was divided into 12 segments and evaluated based on a five-point Likert scale and compared by the Friedman test with a post hoc test. The diagnostic performance of the 3 MRCP was evaluated by the AUC value and compared by Delong's test. The interobserver agreement was evaluated by Kendall's W test.

RESULTS: Compared to NT-MRCP, the acquisition time of CS-NT-MRCP and CS-CFPM-MRCP was significantly decreased (both p < 0.001). There is no significant difference in the overall imaging quality (p > 0.05) between the NT-MRCP and CS-CFPM-MRCP protocols. CS-CFPM-MRCP depicted pancreatic duct and intrahepatic ducts better than CS-NT-MRCP (all p < 0.05) and was comparable with that of the NT-MRCP (all p > 0.05). For identification of abnormalities and diseases associated with MPD anatomy, the mean AUC value for NT-MRCP and CS-CFPM-MRCP were 0.896 (95%CI: 0.834, 0.958) and 0.905 (95%CI: 0.846, 0.964), which were significantly higher when compared to that for CS-NT-MRCP (0.713 [95%CI:0.622, 0.805]) (p = 0.001 and < 0.001). All evaluations showed good to excellent agreement (0.619-0.897).

CONCLUSION: The combination of CS and CFPM is considered feasible for shortening the scan time of 3D free breath MRCP without impairing the imaging quality and CS-CFPM-MRCP is considered feasible for patients suspected with pancreaticobiliary diseases.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. He M, Xu J, Wu Q, et al. Application of Compressed Sensing 3D MR cholangiopancreatography (CS-MRCP) with Contact-Free Physiological Monitoring (CFPM) for Pancreaticobiliary Disorders. Acad Radiol. 2021. PMID: 34756818. doi:10.1016/j.acra.2020.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。